Re-Evaluating Chemotherapy Dosing Strategies for Ovarian Cancer: Impact of Sarcopenia

We investigated the impact of sarcopenia on adjuvant chemotherapy dosing in advanced epithelial ovarian cancer (EOC). The chemotherapy dosing and toxicity of 173 eligible patients who underwent cytoreductive surgery and adjuvant chemotherapy at a single institution were analyzed. Patients with a ske...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Rushi, Polen-De, Clarissa, McGree, Michaela, Fought, Angela, Kumar, Amanika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670337/
https://www.ncbi.nlm.nih.gov/pubmed/37999108
http://dx.doi.org/10.3390/curroncol30110688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670337/
https://www.ncbi.nlm.nih.gov/pubmed/37999108
http://dx.doi.org/10.3390/curroncol30110688

Ejemplares similares